RxDoctor Payments Data

Mary Crecelius

Women's Health · Bloomsdale, MONPI 1841272861

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $632 and has fallen 76.1% since, to $151 in 2025.

$1,760in general payments, 2019–2025

Across 61 payments — averaging $28.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Myriad Genetic Laboratories, Inc.$415
  • AbbVie$383
  • AstraZeneca$124
  • Nestle Healthcare Nutrition Inc.$73
  • Lilly USA, LLC$72
  • Idorsia Pharmaceuticals US Inc$70
  • plus $623 from 16 others

What the payments were for

  • Food & beverage$1,760100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,760 in reported general payments places this provider in the 80th percentile of 208 women's health providers in Missouri.

See all women's health providers in Missouri

Medicare billing

Part B allowed, 2024
$1,920
Medicare patients
40
Services billed
49

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol82$4,278
ProgesteroneProgesterone, Micronized59$2,067
Estradiol (Once Weekly)Estradiol22$1,906
Calcitonin-SalmonCalcitonin,salmon,synthetic16$756
ValacyclovirValacyclovir Hcl26$722
Clobetasol Propionate31$634
Fesoterodine Fumarate ErFesoterodine Fumarate12$290
Ibandronate Sodium14$243
Venlafaxine Hcl ErVenlafaxine Hcl22$196
Oxybutynin Chloride11$145
Vitamin D2Ergocalciferol (Vitamin D2)25$130
Fluconazole19$103
Alendronate Sodium15$47
Levothyroxine Sodium13$21

Paid to pharmacies, not to this prescriber.

Other women's health in Bloomsdale

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →